We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mindray Demonstrates Hematology and Total Laboratory Automation Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Mindray (Shenzhen, China) is returning to ADLM after five years to unveil cutting-edge lab innovations and clinical insights.

At ADLM 2025, Mindray is highlighting the MT 8000 Intelligent TLA Solution designed for streamlined, automated laboratory operations. The MT 8000 Intelligent TLA Solution promises to revolutionize lab operations with unmatched flexibility and automation across five critical disciplines. Mindray is also highlighting the M6000 Laboratory Automation System that can empower ultra-high volume laboratories with high processing speed, less hands-on time, great cost efficiency, and standardized analytical quality.

Image: Mindray is unveiling cutting-edge lab innovations and clinical insights at ADLM 2025 (Photo courtesy of Mindray)
Image: Mindray is unveiling cutting-edge lab innovations and clinical insights at ADLM 2025 (Photo courtesy of Mindray)

Visitors to Mindray’s booth at ADLM 2025 can also experience its ALL IN ONE Hematology Solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. It enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and a high demand for turnaround times.

The focus is also on the CAL 9000 New Generation Cellular Analysis Line that showcases Mindray's expertise and innovation for large-volume hematology laboratories. Mindray is also showcasing the M1000 chemistry and immunoassay integrated solution for large-scale laboratories alongside the M980 chemistry and immunoassay integrated solution for mid-scale laboratories.

Mindray is presenting the FA-N60 next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. In addition, visitors to the company’s booth can experience the CX-6000 Series next-generation mid-end automated coagulation analyzer that has been developed based on the CX-9000 Series platform.

Also being highlighted at ADLM 2025 is the Mindray EU 8600 (and EU 8600 GT) fully automated urinalysis system designed for high-throughput laboratories, featuring multi-depth-of-field fusion, vibration-proof system, 2K full-color clear imaging, and high analysis volume for sediment particles. In addition to presenting innovative breakthroughs,

Additionally, Mindray is also holding expert-led workshops shaping the future of laboratory diagnostics. This includes a workshop on hs-cTnI (high-sensitivity cardiac troponin I) and expert-led discussions on advancing myocardial injury management. Mindray’s focus on high-sensitivity cardiac troponin I clinical insights highlights important advances and ongoing challenges in myocardial injury management—an essential conversation for improving patient outcomes.

Related Links:
Mindray


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Automatic Hematology Analyzer
LABAS F9000

Latest ADLM 2025 News

AI to Revolutionize Testing and Treatment of Lyme Disease
29 Jul 2025  |   ADLM 2025

Breaking Research to Make Testing for Gynecologic Cancers More Equitable and Accurate
29 Jul 2025  |   ADLM 2025

Clinical Data on New Assay Panel Demonstrates Accurate Assessment of Pancreatic Cancer Risk
29 Jul 2025  |   ADLM 2025